Christopher Sarchi serves as Executive at Replimune Group, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Sarchi has executed 5 insider transactions totaling $119.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 19, 2025 involved receiving (via award) 35,000 shares valued at $0.
Christopher Sarchi currently holds 158,088 shares of Replimune Group, Inc. (REPL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Sarchi has been a net seller of REPL stock. They have purchased $0 and sold $119.1K worth of shares.
Christopher Sarchi's most recent insider trade was on Dec 19, 2025, when they sold 35,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $9.10 |
| Discretionary |
| May 16, 2024 | REPL | $14.4K | Sale | 2,218 | $6.47 | Discretionary |
| Apr 1, 2024 | REPL | $0 | Award | 22,225 | $N/A | Discretionary |
| Nov 16, 2023 | REPL | $57.4K | Sale | 5,255 | $10.92 | Discretionary |